Peking Union Medical College Hospital
Peking Union Medical College Hospital - Department of Nephrology
China · 博士
The Department of Nephrology at Peking Union Medical College Hospital was founded by Professor Bi Zengqi in 1979 and is one of the earliest nephrology departments in China. It has extensive experience in treating refractory nephrotic syndrome, IgA nephropathy, lupus nephritis, and ANCA-associated vasculitis, serving as an important center for difficult and severe kidney disease diagnosis and treatment in China.
学术历史
In 1979, Professor Bi Zengqi established the nephrology group at Peking Union Medical College Hospital, one of the earliest in China. In 1980, a nephrology laboratory and hemodialysis unit were established. In the 1990s, young scholars returned from abroad, injecting new vitality. The department led the nation in using cyclosporine A for refractory nephrotic syndrome, anti-PLA2R antibody diagnosis of membranous nephropathy, and rituximab for refractory nephrotic syndrome. In 2016, Professor Li Xuemei first reported internationally that hydroxychloroquine effectively reduces proteinuria in IgA nephropathy.
当前状态
The department has developed into a modern nephrology center including outpatient, inpatient, blood purification (including peritoneal dialysis), and laboratory services. It has 3 professors, 2 doctoral supervisors, and 10 associate professors, with 90% of attending physicians holding doctoral degrees. Over 50% of patients are difficult and severe cases, many referred nationally for refractory glomerular diseases. It has distinctive strengths in membranous nephropathy (anti-PLA2R antibody), IgA nephropathy, diabetic nephropathy, and hereditary kidney diseases.
实验室 / 研究中心
关键人物
Chen Limeng
Department Chief, Professor, Chief Physician, Doctoral Supervisor
JASN Associate Editor (2017-2023), President of the Chinese Geriatric Society Nephrology Branch. Specializes in hereditary kidney diseases and immune/metabolic kidney diseases. Published 100+ papers in Lancet, JASN, Hypertension. Leads 20+ national and ministry-level grants.
Li Xuemei
Professor, Chief Physician, Doctoral Supervisor
Important contributions to IgA nephropathy treatment. In 2016, with Associate Professor Gao Ruitong, first reported internationally that hydroxychloroquine effectively reduces IgA nephropathy proteinuria, and registered a large-scale US RCT for HCQ in IgAN.
标志性成果
- First in China to use cyclosporine A for refractory nephrotic syndrome (1980s)
- First international report of hydroxychloroquine for IgA nephropathy (2016)
- Translational application of anti-PLA2R antibody in membranous nephropathy (2013)
学术资源
证据
师资
2 位相关教师
知名:陈丽萌、李雪梅
研究产出
陈丽萌教授在Lancet/JASN/Hypertension等发表国际论文100余篇
就业去向
发现信息有误? 提交纠错